Navigation Links
'Watchful Waiting' Safe With Low-Risk Prostate Cancers
Date:3/16/2009

Study suggests close monitoring offers some men better quality of life

MONDAY, March 16 (HealthDay News) -- Refusing immediate treatment can be safe for men with low-risk prostate cancer if they're closely monitored, new research finds.

The multi-center study of American and Canadian patients was conducted between 1991 and 2007.

"When or if to treat men with low-risk prostate cancer has always been a challenging question that faces patients and urologists," study author Dr. Scott Eggener, an assistant professor of surgery at the University of Chicago Medial Center, said in a news release from the university. "Some men may be rushing into treatment that won't necessarily benefit them, prevent problems or prolong life. Close observation in certain patients may provide and maintain quality of life without increasing the chances of the cancer spreading."

Between 20 percent and 50 percent of American men diagnosed with prostate cancer will eventually die from a cause other than their prostate cancer, he noted. This shows that a large number of patients don't benefit from treatment for their prostate cancer.

The 262 men in this study who decided on "watchful waiting" instead of immediate treatment met the following criteria: under age 75; prostate specific antigen (PSA) below 10 ng/ml; clinical stage T1-T2a; Gleason score 6 or below; and three or fewer positive cores at diagnostic biopsy. The patients underwent a restaging biopsy and had no treatment for six months following the repeat biopsy. They then had physical exams and PSA tests every six months with biopsies recommended every one to two years.

Of the men in the study, 43 eventually decided to have treatment or had evidence of cancer progression that prompted a doctor's recommendation to begin treatment. Following radiation or surgery, all but one of those 43 patients were cured of their prostate cancer. The remaining 219 patients remained on watchful waiting without evidence of cancer progression.

"Active surveillance with delayed treatment, if necessary, for select patients appears to be safe and associated with a low risk of metastatic spread," the researchers concluded.

The study was published in the March 16 issue of Urology.

"Active surveillance is not a total disregard for patients with prostate cancer. Instead, it identifies men unlikely to be affected by their cancer and encourages frequent monitoring, and then starting therapy at a later appropriate time if needed. Cure rates appear to be identical when these men choose immediate treatment or delayed treatment when prompted by new information about their condition," Eggener said.

More information

The Prostate Cancer Foundation has more about watchful waiting.



-- Robert Preidt



SOURCE: University of Chicago Medical Center, news release, March 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Radiation seed implant decreases risk of death over watchful waiting
2. Keep a Watchful Eye on Sugary Beverage Consumption
3. Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab
4. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
5. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
6. New Heart Pump Helps Women Awaiting Transplants
7. Governor Rendell Offers Coverage to 29,000 on AdultBasic Waiting List; Unveils New Policy to Improve Quality of Care for the Low-Income and Pennsylvanians With Disabilities
8. Blacks awaiting lung transplants more likely to die or be denied than whites
9. Blacks Awaiting Lung Transplants Face Poorer Outcomes
10. Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008
11. Hidden heart condition increases the risk of death in patients waiting for kidney transplants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Watchful Waiting' Safe With Low-Risk Prostate Cancers
(Date:5/24/2016)... ... 2016 , ... Global Lyme Alliance (GLA), a leading nonprofit ... has named Scott Santarella as its new CEO. , Santarella is former ... San Francisco, where he successfully helped to grow the organization from a regional ...
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers ... of protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The ... Interventions (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts ... ‘El Centro del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was ... offer something special for this often overlooked neighborhood. Located at 609 E. 6th ...
(Date:5/24/2016)... ... May 24, 2016 , ... Celebration is in ... kicked off its 5th Annual Photo Contest. The label contest is underway, and ... year's prizes include a GoPro Hero4, a 40-inch high-definition flat-screen television, an Apple ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... On the ... took the time to summarize the weight loss process: , New patients have a ... Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are 15 ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... , May 23, 2016 The ... USD 5.0 billion by 2022, according to a new ... of medical waste coupled with the lack of centralized ... expected to drive the demand for reprocessed medical devices ... as compared to that of the original device is ...
(Date:5/22/2016)... DUBLIN , May 23, 2016 ... to develop its anti-fibrotic and anti-inflammatory compound DS102 ... well as in non-alcoholic steatohepatitis (NASH) patients. ... is significantly sequestered in lung tissue and has ... tissue after oral administration. The Company will publish ...
Breaking Medicine Technology: